FAKTOR OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 11:20:23 26/06/2024 pm IST | ||
| 11.45 EUR | +1.69% |
|
| Current month | +11.15% | ||
| 1 month | +7.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 11.45 | +1.69% |
| 25/24/25 | 11.26 | +0.72% |
| 24/24/24 | 11.18 | -0.53% |
| 21/24/21 | 11.24 | +2.84% |
| 20/24/20 | 10.93 | +5.20% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 11:20 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PN2EDW |
| ISIN | DE000PN2EDW1 |
| Date issued | 09/11/2021 |
| Strike | 91.08 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 30 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 36.33 € |
|---|---|
| Lowest since issue | 5.67 € |
| Spread | 0.11 € |
| Spread % | 0.95% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.05
USD
Spread / Average Target
+5.46%
- Stock Market
- Certificates
- Certificat
